SCHEMBL28891488

SCHEMBL28891488

CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(F)c3)ncnc2cc1OC1CCOC1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.88
▸ ERBB2 P04626 7/20 0.88
▸ GAK O14976 2/20 0.88
▸ ABL1 P00519 2/20 0.88
▸ LCK P06239 2/20 0.88
▸ MET P08581 2/20 0.88
▸ PHKG2 P15735 2/20 0.88
▸ BLK P51451 2/20 0.88
▸ IRAK1 P51617 2/20 0.88
▸ DYRK1A Q13627 2/20 0.88
▸ ERBB4 Q15303 2/20 0.88
▸ HIPK4 Q8NE63 2/20 0.88
▸ EPHA6 Q9UF33 2/20 0.88
▸ CIT O14578 1/20 0.88
▸ EPHB6 O15197 1/20 0.88
▸ RIPK2 O43353 1/20 0.88
▸ STK10 O94804 1/20 0.88
▸ LYN P07948 1/20 0.88
▸ RET P07949 1/20 0.88
▸ CHRM2 P08172 1/20 0.88

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9883170 0.94 EGFR (0.86) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL231073 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL185621 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
SCHEMBL15597268 0.94 EGFR (0.85) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL232772 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL185786 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL2865630 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL2865634 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL231072 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK
Afatinib SCHEMBL2269415 0.94 EGFR (1.00) EGFRERBB2GAKABL1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297865-A Use of heterocyclic compound-containing composition for preparing medicine for treating lung cancer 黄泳华 2020-06-19 — — CN claimed
CN-111297865-A Use of heterocyclic compound-containing composition for preparing medicine for treating lung cancer 黄泳华 2020-06-19 — — CN disclosed
Send feedback